Department of Oncology, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China
Case Report
Positive Response to Camrelizumab and Apatinib Combination Therapy in a Patient with Stage IIIC1 Cervical Cancer: A Case Report
Author(s): Zhi-Ping Liu, Si-Han Liu, He Zhao, Fangying Ruan, Bai Xu* and Da-Xin
Advanced cervical cancer has a poor prognosis and few effective therapy options. However, immunotherapy has been approved by the FDA and
has shown promising results for patients with cervical cancer. In this report, we present the case of a patient with stage IIIC1 cervical cancer who
exhibited a positive response to a combination of Camrelizumab and Apatinib after radio-chemotherapy. Our findings suggest that the combination
of Camrelizumab and Apatinib may provide a valuable therapeutic option for advanced cervical cancer patients who do not respond to radiochemotherapy
alone... Read More»
DOI:
10.37421/2684-4915.2023.7.258
Clinical and Medical Case Reports received 40 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 